Today: 11 June 2026
Intel Reclaims Fab 34 From Apollo in $14.2 Billion Deal as AI Turnaround Faces Next Test
9 April 2026
1 min read

Intel Reclaims Fab 34 From Apollo in $14.2 Billion Deal as AI Turnaround Faces Next Test

SANTA CLARA, California, April 9, 2026, 04:14 PDT.

Intel Corp has completed the $14.2 billion repurchase of Apollo’s 49% stake in the Fab 34 joint venture in Ireland, restoring full ownership of a key European factory. A filing on Wednesday showed the chipmaker funded the move with cash and a $6.5 billion bridge loan, a short-term facility it plans to refinance.

The timing matters. Intel is trying to show its turnaround under Chief Executive Lip-Bu Tan is moving from cuts and balance-sheet repair to tighter factory control and fresh AI-linked work, with first-quarter results due on April 23 and two AI announcements in as many days.

Fab 34 in Leixlip makes Core Ultra and Xeon 6 chips using Intel’s current production technology. Apollo bought the 49% stake for $11.2 billion in 2024, giving Intel fresh capital while preserving balance-sheet strength as it kept spending on factories in Europe and the United States.

When Intel unveiled the buyback last week, Chief Financial Officer David Zinsner said the old deal was “the right structure at the right time.” He said Intel now had a “stronger balance sheet” and “improved financial discipline,” and the company expects the repurchase to lift per-share earnings and support its credit profile from 2027. Intel Corporation

Intel said earlier this week it would join Elon Musk’s Terafab chip project with SpaceX and Tesla. Tan called the plan a “step change” in how chip logic, memory and packaging are built, while D.A. Davidson analyst Gil Luria said the tie-up was an “important step”; Intel shares jumped more than 2% after the announcement. Reuters

Intel also rolled out a new design with SambaNova on Wednesday that pairs Xeon 6 CPUs — general-purpose chips that act as the main brains of servers — with graphics chips and SambaNova’s own processors for AI agents. The companies are targeting inference, the stage when AI systems answer prompts and carry out tasks, and Kevork Kechichian, who runs Intel’s data-center group, said Xeon remains a “mature, proven foundation” for that work. Newsroom

The backdrop is rough. Nvidia, dominant in AI accelerators, is pushing harder into CPUs, while AMD remains Intel’s main rival in standard server processors; at the same time Intel is still trying to prove that 18A, its next-generation chipmaking process, can win outside manufacturing customers.

But there are still clear snags. The Fab 34 repurchase relies in part on a bridge loan Intel still needs to refinance, and Intel itself warned debt-market conditions and semiconductor demand could change the expected benefit. In March, Reuters reported that only a small percentage of chips produced on 18A were then good enough for customers, though Intel said yields were improving monthly.

Intel reports first-quarter results after the market close on April 23 and will hold a conference call at 2 p.m. Pacific time. That should give investors a cleaner read on whether full control of Fab 34 and a burst of AI deals are feeding through to the business.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Nvidia Stock Edges Up, but Broadcom’s Google TPU Deal Raises Stakes in AI Chip Race
Previous Story

Nvidia Stock Edges Up, but Broadcom’s Google TPU Deal Raises Stakes in AI Chip Race

American Airlines Faces FAA Fine Over Drug-Testing Lapses in New Test for 2026 Turnaround
Next Story

American Airlines Faces FAA Fine Over Drug-Testing Lapses in New Test for 2026 Turnaround

Go toTop